 (BrJ7 Ophthalmol 1992; 76: 602-606) 
Human corneal grafts are not rejected in the majority of recipients unlike allografts of most other organs, and this lower susceptibility to rejection is termed 'immunological privilege'.' However privilege is relative and corneal grafts in eyes that have suffered inflammation have a high failure rate. 2 The main cause of graft failure is immunological rejection3 but the mechanisms of corneal graft rejection are poorly understood. It has been proposed that CD4+ T-helper cells, CD8+ T-cytotoxic cells, and inflammatory cells are involved in solid organ graft rejection. 4 Though recognition of foreign antigens via the afferent limb of the immune system by specific T-cells is important in mediating corneal graft failure' the precise effector mechanism is unknown. There is little direct evidence to support the role of cytotoxic CD8+ T-cells as the effector cells of corneal graft rejection, though anti-donor splenic CD8+ T-cells have been generated in vivo from corneal grafted animals. 6 However the association of a particular in vitro immune response with graft rejection does not necessarily imply that it is a requirement for rejection. ' It would seem from observations of the rejection of other organs that the CD4+ T-cell plays a critical role in allograft rejection, whereas the CD8+ T-cell does not.8-" Indirect evidence derived from immunohistochemical analysis of cells infiltrating rejecting corneal allografts in rats failed to identify significant infiltration by CD8+ cells though a heavy infiltration of macrophages was identified." 2 [10] [11] [12] weeks old received intraperitoneal injections of 1 ml of ascites containing 6 mg of OX8 (anti-CD8) mAb three times a week. A second group was treated three times a week with 1 ml of a cocktail containing two noncompeting anti-CD4 mAbs, OX35 (0 75 mg) and OX38 (2 5 mg) which deplete CD4+ T-cells.'s The third group was injected three times a week with 1 ml of a non-reactive control mAb OX21 (anti-human C3b) that does not react with rat antigens. Treatment was continued for 48 days. On day 16 after the initial injection of mAb the animals received a penetrating allogeneic Lewis corneal graft into the right eye.
MONITORING OF DEPLETION
The ability of the antibody injections to deplete circulating cells was monitored at 7-10 day intervals by flow cytometry. Blood samples of 1 ml were obtained from the tail vein of each CD8-and CD4-depleted rat. After separation of leucocytes on a Ficoll density gradient (specific gravity 1 083), cells were washed and surface phenotyped. Leucocytes from the anti-CD8 treated rats were stained using a primary mouse anti-CD8 mAb (OX8) followed by fluorescein conjugated FITC-F(ab')2 rabbit anti-mouse IgG, which fluoresces green (Dako Ltd, High Wycombe, UK), containing 1% normal rat serum to block anti-rat Ig cross-reactivity. Leucocytes prepared from the anti-CD4 treated rats were double stained using a five-stage staining protocol (1) mAb R73 (anti-T-cell receptor); (2) FITC-F(ab')2 anti-mouse IgG in 1% normal rat serum; (3) The percentage of blood leucocytes that stained were either CD4' or CD8' is shown against the day of treatment. The day of the first treatment is day 0 and the rats were grafted on day 16 . difference compared to the survival times of 2 grafts in injected recipients (Fig 2A) .
32%
Anti-CD8 (OX8) treated recipients The six allografts were rejected between 7 and 27 4 days with a median rejection time of 12 days. 20 .4% There was no difference in the rejection times compared with graft rejection in the OX2 1 treated controls (Fig 2B) .
Anti-CD4 (OX351OX38) treated recipients Six technically successful allografts were followed 3 .. i. l
Fig3A
There was no correlation between the amount of CD4+ cell depletion at the time of grafting and the eventual graft survival. Rejected allografts became opaque and vascularised and, though after several weeks the opacity partially cleared, the grafts remained vascularised (Fig 3A) . In contrast, the long term surviving grafts remained clear and though vessels grew up to the wound they did not grow onto the graft (Fig 3B) . Figure 4 Immunoperoxidase staining with mAb OX42 in a section from the centre ofa rejected graft in the anti-CD8 depleted group showing heavy infiltration of macrophages.
Histology ofgrafts Syngeneic grafts had low numbers of infiltrating leucocytes staining for the leucocyte common antigen CD45 (OX1) and most of these appeared to be macrophages marked by OX42. Rejected grafts in the untreated, CD4+ depleted, and CD8+ depleted animals had a heavy infiltration of macrophages staining with OX42 (Fig 4) 
